🔴 Noveris Health Sciences is trading 11.43% down today amid proposed convertible-debenture dilution overhang

Noveris Health Sciences is trading 11.43% down at CA$0.15, amid investor pressure linked to a proposed private placement of up to CA$500,000 in convertible debentures.

• The price is below the recent CA$0.17 close.
• The placement is expected to close August 28, 2026, with conversion into shares and warrants, creating a potential dilution overhang.
• Biotech is down 2.31% amid renewed concerns about a hawkish Federal Reserve stance; no separate confirmed company announcement was identified on August 28.